--- title: "Green Thumb Industries Inc. (GTBIF.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/GTBIF.US.md" symbol: "GTBIF.US" name: "Green Thumb Industries Inc." industry: "Pharmaceuticals" datetime: "2026-05-20T08:13:41.914Z" locales: - [en](https://longbridge.com/en/quote/GTBIF.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/GTBIF.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/GTBIF.US.md) --- # Green Thumb Industries Inc. (GTBIF.US) ## Company Overview Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. | Item | Detail | |------|--------| | Industry | Pharmaceuticals | | Exchange | US Market | | Website | [www.gtigrows.com](https://www.gtigrows.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: B > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:13.000Z **Overall: B (0.38)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 21 / 190 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock. **Multi Score**: B #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 4.83% | | | Net Profit YoY | 140.98% | | | P/B Ratio | 0.86 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1629029512.79 | | | Revenue | 1195945000.00 | | #### Multi Score Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 6.55% | C | | Profit Margin | 10.14% | B | | Gross Margin | 47.85% | B | | Revenue YoY | 4.83% | C | | Net Profit YoY | 140.98% | A | | Total Assets YoY | 10.22% | B | | Net Assets YoY | 5.02% | C | | Cash Flow Margin | 244.56% | A | | OCF YoY | 4.83% | C | | Turnover | 0.44 | C | | Gearing Ratio | 33.00% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Green Thumb Industries Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "4.83%", "rating": "" }, { "name": "Net Profit YoY", "value": "140.98%", "rating": "" }, { "name": "P/B Ratio", "value": "0.86", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "1629029512.79", "rating": "" }, { "name": "Revenue", "value": "1195945000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "B", "indicators": [ { "name": "ROE", "value": "6.55%", "rating": "C" }, { "name": "Profit Margin", "value": "10.14%", "rating": "B" }, { "name": "Gross Margin", "value": "47.85%", "rating": "B" }, { "name": "Revenue YoY", "value": "4.83%", "rating": "C" }, { "name": "Net Profit YoY", "value": "140.98%", "rating": "A" }, { "name": "Total Assets YoY", "value": "10.22%", "rating": "B" }, { "name": "Net Assets YoY", "value": "5.02%", "rating": "C" }, { "name": "Cash Flow Margin", "value": "244.56%", "rating": "A" }, { "name": "OCF YoY", "value": "4.83%", "rating": "C" }, { "name": "Turnover", "value": "0.44", "rating": "C" }, { "name": "Gearing Ratio", "value": "33.00%", "rating": "B" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 13.44 | 20/190 | 59.17 | 33.56 | 16.08 | | PB | 0.86 | 41/190 | 1.03 | 0.87 | 0.75 | | PS (TTM) | 1.36 | 38/190 | 1.61 | 1.38 | 1.19 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Cormedix (CRMD.US) | A | A | B | C | B | A | | 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B | | 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B | | 04 | Roche (RHHBY.US) | A | B | B | D | B | B | | 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-05-11T04:00:00.000Z Total Analysts: **9** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 9 | 100% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 7.03 | | Highest Target | 20.00 | | Lowest Target | 17.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GTBIF.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GTBIF.US/norm.md) - [Related News](https://longbridge.com/en/quote/GTBIF.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GTBIF.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**